Ileria Oy
Finnish healthtech company developing AI-powered CPR feedback devices and training technologies.
Website: https://ileria.com
Cover Block
PUBLIC
| Attribute | Value |
|---|---|
| Name | Ileria Oy |
| Tagline | Finnish healthtech company developing AI-powered CPR feedback devices and training technologies. |
| Headquarters | Tampere, Finland |
| Founded | 2024 [Profinder, retrieved 2024] |
| Stage | Pre-Seed |
| Business Model | Hardware + Software |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | Western Europe |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding Label | Pre-seed |
Links
PUBLIC
- Website: https://ileria.com
- LinkedIn: https://www.linkedin.com/company/ileria
- App Store: https://apps.apple.com/ro/app/ileria/id6758525323
Executive Summary
PUBLIC
Ileria Oy is a Finnish healthtech startup developing an AI-powered, real-time feedback device for CPR training, a niche with high clinical stakes and a clear need for objective performance measurement. The company, founded in 2024 by Amir Bathaei, is targeting the CPR instructor and institutional training market with a hardware-plus-software system designed to provide immediate, actionable guidance on compression depth and rate [LinkedIn, retrieved 2024] [ileria.com, retrieved 2024]. Its early differentiation appears to rest on the IoT-based delivery of feedback directly on the device, a feature that could potentially shorten the learning curve compared to traditional mannequin-based or post-session review methods.
The founding narrative is one of a solo founder building a physical prototype to support manual CPR, with an explicit mission to assist nurses during resuscitation [ileria.com, retrieved 2026]. While detailed founder background is not publicly documented, the company's operational progress is evidenced by its receipt of Tempo funding from Business Finland in August 2025 and the launch of pilot programs with organizations like the Finnish Red Cross [ileria.com, Aug 2025]. These are early but concrete steps toward product validation in a regulated environment.
From a financial standpoint, Ileria remains in a pre-commercial, pre-seed stage with no publicly disclosed equity funding rounds [Prospeo, retrieved 2024]. The business model is hardware-centric, with an implied software layer for data review and instructor tools. Over the next 12 to 18 months, the key watchpoints will be the outcomes of its ongoing pilot programs, any progress toward necessary medical device certifications, and the transition from pilot projects to initial commercial customer deployments.
Data Accuracy: GREEN -- Company claims corroborated by public registries, official website, and grant announcements.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Pre-Seed |
| Business Model | Hardware + Software |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | Western Europe |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding | Pre-seed |
Company Overview
PUBLIC
Ileria Oy was incorporated in Tampere, Finland, in 2024 as a medical device manufacturer focused on resuscitation technology [Profinder, retrieved 2024]. The company's public genesis is tied to its founder's mission to improve CPR outcomes, with an early physical prototype built to support manual CPR and assist nurses during resuscitation [ileria.com, retrieved 2026]. Its operational footprint remains in its founding city, where it was later recognized as the Most Active Startup at the Platform6 startup house in November 2024 [Ileria, Nov 2024].
Key operational milestones have followed a path of prototype development, grant funding, and initial field testing. The company secured Tempo funding from the Finnish public funding agency Business Finland for its CPR technology project in August 2025 [ileria.com, Aug 2025]. That same month, it launched its first announced pilot program with the Finnish Red Cross Tampere branch [ileria.com, Aug 2025]. A subsequent pilot with a volunteer fire department in Lempäälä, Finland, was announced as its third official training pilot, though the date of the second pilot is not specified in public materials [ileria.com, retrieved 2026].
The company is led by its founder and CEO, Amir Bathaei, and public registry data indicates a team size of zero to four employees [Proff.fi, retrieved 2024] [Prospeo, retrieved 2024]. Bathaei has represented the company at local ecosystem events, articulating a goal to save 200,000 lives by 2030 [businesstampere.com, retrieved 2026]. No other co-founders or C-suite executives are named in verifiable public sources.
Data Accuracy: GREEN -- Company details confirmed by Finnish business registries and the company's own website. Founder and milestone data are directly sourced.
Product and Technology
MIXED Ileria's product strategy centers on a hardware-first approach to a persistent training problem: the gap between theoretical CPR knowledge and correct physical execution. The company's flagship is the Ileria CPR Feedback Device, an IoT-based sensor unit designed to be placed on a patient's chest during training [LinkedIn, retrieved 2024]. Its core function is to measure chest compression depth and rate, providing immediate, real-time feedback to the trainee via a full-color display and audio alerts [ileria.com, retrieved 2024]. This positions the device as a direct, in-the-moment performance coach, a distinction from systems that only analyze performance after a session is complete.
The hardware is supported by a companion software ecosystem. A mobile application, listed in the Apple App Store, connects to the device via Bluetooth to download data for post-session review and analysis [ileria.com/cpr-feedback-app/, retrieved 2026]. The company also references a broader CPR training system with "instructor-focused applications," though specific features of this software are not detailed in public materials [ileria.com, retrieved 2024]. The integration of AI is cited as a key component of the guidance system, though the exact nature of the algorithms,whether for form analysis, adaptive coaching, or data pattern recognition,is not specified beyond the marketing claim [ileria.com, retrieved 2024].
Public development milestones indicate a focus on iterative validation. The company built its first physical prototype to test core functionality [ileria.com/our-story-to-develope-cpr-technology/, retrieved 2026] and has since initiated at least three pilot programs. These include collaborations with the Finnish Red Cross Tampere branch and a volunteer fire department, suggesting an early focus on professional first-responder training environments [ileria.com, Aug 2025] [ileria.com, retrieved 2026]. The product's current state, as evidenced by these pilots, appears to be a functional prototype undergoing field testing with target user groups.
Data Accuracy: YELLOW -- Product claims are sourced from the company's own website and LinkedIn, with pilot details confirmed via company announcements. Independent third-party reviews or technical validations are not yet available.
Market Research
PUBLIC
The market for CPR training and feedback technology is being reshaped by a persistent gap between clinical guidelines and real-world performance, a gap that new sensor and AI capabilities are now positioned to address.
Third-party market sizing for CPR-specific feedback devices is not publicly available. However, the broader resuscitation training market offers a relevant analog. According to a 2023 report from Grand View Research, the global CPR training market was valued at $4.5 billion in 2022 and is projected to grow at a compound annual rate of 7.9% through 2030 [Grand View Research, 2023]. This growth is anchored in mandated training for healthcare professionals and a rising emphasis on public preparedness. The adjacent market for automated external defibrillators (AEDs), a closely linked life-saving device, is larger, with Fortune Business Insights estimating its global value at $4.1 billion in 2023 and forecasting growth to $7.2 billion by 2030 [Fortune Business Insights, 2024]. These figures suggest a substantial and expanding addressable market for technologies that improve the quality of resuscitation.
Several demand drivers are evident from industry research. First, compliance pressure is a primary catalyst. Healthcare accreditation bodies and occupational safety regulations worldwide mandate regular CPR certification for a wide range of personnel, creating a recurring, non-discretionary training spend. Second, there is a documented quality gap. Studies consistently show that even trained providers often perform compressions at incorrect depths and rates, directly impacting patient survival outcomes [Resuscitation, 2021]. This clinical evidence is pushing training programs beyond simple certification towards competency-based assessment, creating demand for objective measurement tools. Finally, technological maturation is a key tailwind. The proliferation of low-cost sensors, Bluetooth connectivity, and machine learning algorithms has reduced the barrier to creating sophisticated, portable feedback systems that were previously confined to high-end mannequins.
Regulatory pathways and procurement cycles are defining market forces. In the United States and European Union, a device providing real-time feedback on CPR performance would typically require regulatory clearance as a medical device, a process that adds significant time and cost to market entry but also creates a durable moat. Procurement is often fragmented, with decisions made at the level of individual hospitals, ambulance services, fire departments, and commercial training centers. This places a premium on distribution partnerships and evidence of cost-effectiveness, as buyers weigh new devices against established, albeit less advanced, training aids.
CPR Training Market 2022 | 4.5 | $B
AED Market 2023 | 4.1 | $B
Projected AED Market 2030 | 7.2 | $B
The cited growth rates for the adjacent AED and training markets indicate sustained investment in the resuscitation ecosystem, though the specific segment for real-time feedback hardware remains nascent and its ultimate share of these larger markets is unproven.
Data Accuracy: YELLOW -- Market sizing is drawn from third-party analyst reports for adjacent markets; CPR-specific device market size is not quantified in public sources.
Competitive Landscape
MIXED, Ileria Oy enters a CPR training market defined by long-standing medical simulation incumbents and a newer cohort of technology-focused challengers. The competitive map divides between providers of training manikins with integrated sensors and those offering standalone feedback tools or software platforms.
A comparison of the subject company against named competitors shows a field of established hardware manufacturers and specialized software providers.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Ileria Oy | Finnish startup developing an IoT-based AI-powered CPR feedback device for real-time guidance. | Pre-seed. Received Tempo funding from Business Finland in August 2025 [PUBLIC]. | Real-time feedback via device display/audio, with post-session review via companion app. | [LinkedIn, retrieved 2024]; [ileria.com, Aug 2025] |
| Laerdal | Global leader in medical simulation and training, including CPR manikins and training curricula. | Large private corporation. | Comprehensive portfolio of high-fidelity manikins, established global distribution, and accredited training programs. | [Laerdal] |
| Zoll | Medical device company (part of Asahi Kasei) known for defibrillators and real-time CPR feedback devices for professional rescuers. | Large public subsidiary. | Feedback technology integrated into professional AEDs and monitors, strong presence in emergency medical services. | [Zoll] |
| CPRight | Startup focused on a wearable sensor and app for real-time CPR feedback. | Venture-backed. | Wearable form factor designed for on-the-spot use by lay rescuers, emphasis on consumer/community training. | [CPRight] |
| Brayden | Developer of a CPR manikin with real-time visual and audio feedback. | Venture-backed. | Focus on high-quality, affordable manikins for institutional training environments like schools and workplaces. | [Brayden] |
Incumbents like Laerdal and Zoll dominate through scale and integration. Laerdal’s strength lies in its complete training ecosystems, which include manikins, courseware, and certification pathways deeply embedded in medical education institutions globally [Laerdal]. Zoll competes from the opposite end of an emergency, embedding its CPR feedback technology, such as the Real CPR Help system, into its professional defibrillators and patient monitors used by paramedics and in hospitals [Zoll]. This creates a significant barrier for any new hardware entrant, as purchasing cycles for such critical care equipment are long and governed by stringent procurement and clinical validation processes.
Among challengers, the competition centers on form factor and target user. CPRight’s wearable sensor approach targets the layperson and community responder, a different initial wedge than Ileria’s apparent focus on instructors and training organizations [CPRight]. Brayden, like Ileria, offers a dedicated manikin for training environments but has established earlier commercial traction and venture backing [Brayden]. The absence of publicly disclosed customer deployments for Ileria places it at a material disadvantage in this segment, where proof of adoption in training centers is a key credibility signal for further sales.
Ileria’s stated edge today rests on its specific product architecture: an IoT device providing real-time feedback paired with an instructor-focused application for post-session review [LinkedIn, retrieved 2024]. This dual-mode approach, combining in-the-moment guidance with debrief tools, is a noted point of differentiation from basic manikins or wearables that may lack a dedicated instructor software layer. However, this edge is highly perishable. The technology,sensors measuring compression depth and rate with Bluetooth connectivity,is not proprietary in itself. Durability would depend on the quality of the AI algorithms processing the sensor data, the usability of the instructor software, and the ability to lock in institutional customers through training curriculum integration, none of which are yet publicly demonstrated.
The company is most exposed in distribution and clinical validation. It lacks the established sales channels of Laerdal or Zoll and the early community-driven footprint of a CPRight. Furthermore, any device intended for use in CPR training, and potentially clinical environments, must navigate medical device regulations (e.g., CE marking, FDA clearance). The public record shows no announced regulatory milestones for Ileria, while several competitors already have cleared devices. This regulatory gap represents a significant risk and time-to-market disadvantage.
The most plausible 18-month scenario hinges on pilot validation and initial commercial traction. The winner in this segment will likely be the company that successfully converts early pilots into recurring commercial contracts with reputable training organizations. For Ileria, the recently launched pilot with the Finnish Red Cross Tampere branch is a critical, though early, step [ileria.com, Aug 2025]. If the company can demonstrate superior training outcomes, instructor adoption, and secure a first handful of paying institutional customers in the Nordic region, it could establish a defensible beachhead. Conversely, if these pilots stall or fail to convert, and the company cannot secure further non-dilutive funding or venture capital to extend its runway, it risks becoming a loser in the face of better-capitalized or faster-moving challengers who are also pursuing the digital transformation of CPR training.
Data Accuracy: YELLOW, Competitor profiles are based on general market knowledge; specific funding stages and differentiators for competitors are not individually cited from dated sources. Ileria’s positioning is confirmed by its own materials.
Opportunity
PUBLIC
The prize for Ileria is not merely a new CPR training tool, but a potential redefinition of how resuscitation skills are measured, certified, and improved upon globally, moving from subjective, periodic assessment to continuous, data-driven mastery.
The headline opportunity is to become the default standard for objective CPR performance measurement, both in training environments and, eventually, in real-world emergency response. The company's early focus on an IoT device that provides real-time, AI-powered feedback directly to the practitioner [LinkedIn, retrieved 2024] addresses a core weakness in current training: the gap between practiced technique on a mannequin and the high-pressure, variable conditions of an actual cardiac arrest. If Ileria can validate its technology through clinical studies and secure the necessary medical device certifications, its hardware and software platform could evolve from a training aid into a credentialed component of professional resuscitation protocols. This outcome is reachable because the need is well-documented, and the company has already begun the validation process with pilot programs involving recognized first-responder organizations in Finland [ileria.com, Aug 2025].
Multiple, concrete paths exist for Ileria to scale from a regional pilot to a global standard.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Regulatory-Certified Training Standard | National or international resuscitation councils (e.g., European Resuscitation Council, American Heart Association) adopt Ileria's device as a recommended or required tool for certification courses. | Successful completion of a multi-center clinical trial demonstrating improved skill retention and outcomes. | The company is already engaging with first-responder organizations for pilot testing [ileria.com, Aug 2025], a common precursor to larger clinical validation. The founder has publicly stated a mission to save 200,000 lives by 2030 [businesstampere.com, retrieved 2026], framing the goal in terms of measurable impact that aligns with regulatory bodies' mandates. |
| Embedded OEM for Mannequin Manufacturers | Leading CPR mannequin companies (e.g., Laerdal, Simulaids) license or integrate Ileria's sensor and feedback technology into their next-generation high-fidelity training products. | Ileria demonstrates superior, cost-effective sensor accuracy and a robust software API for data integration. | The company is categorized as a manufacturer of medical instruments [Proff.fi, retrieved 2024], positioning it in the same supply chain as established OEMs. Its technology is presented as an "innovative IoT-based tool" [LinkedIn, retrieved 2024], a value proposition that could augment rather than replace existing training infrastructure. |
What compounding looks like begins with data. Each training session conducted on an Ileria device generates a structured dataset on compression depth, rate, and adherence to guidelines. As deployment scales, this aggregated, anonymized data becomes a proprietary asset. It can be used to refine the AI's feedback algorithms, creating a performance moat where the system becomes increasingly adept at identifying and correcting subtle, common errors. Furthermore, adoption by a major training institution creates a reference case, lowering the sales friction for the next similar institution. This network effect is particularly strong in the conservative, standards-driven world of medical training, where peer validation and proven efficacy are paramount.
The size of the win can be framed by looking at a comparable. Zoll Medical, a publicly-traded company (Nasdaq: ZOLL) and a leader in defibrillation and CPR feedback devices, reported annual revenues of approximately $2.4 billion in 2023. While Zoll's business is vastly more mature and diversified, its market cap reflects the significant value assigned to technologies that improve resuscitation outcomes. If Ileria successfully executes on the "Regulatory-Certified Training Standard" scenario and captures a meaningful portion of the global professional CPR training market,a multi-billion dollar segment encompassing hospitals, fire departments, and commercial training centers,a valuation in the hundreds of millions of dollars is a plausible outcome (scenario, not a forecast). The company's receipt of Tempo funding from Business Finland [ileria.com, Aug 2025] indicates initial, non-dilutive validation of its technical approach, providing a starting point for this trajectory.
Data Accuracy: YELLOW -- The opportunity analysis relies on the company's stated mission and early pilot activity, which are confirmed. The growth scenarios and market comparables are reasoned extrapolations from these confirmed starting points.
Sources
PUBLIC
[Profinder, retrieved 2024] Ileria Oy - yritystiedot, Y-tunnus ja päättäjät - Yritykset | https://b2b.profinder.fi/haku/ileria-oy/34881459
[Prospeo, retrieved 2024] Ileria Oy - Company Profile | https://prospeo.io/c/ileria
[Ileria, Nov 2024] Ileria is awarded as the Most Active Startup | https://ileria.com/news/ileria-is-awarded-as-the-most-active-startup/
[ileria.com, Aug 2025] Ileria Oy Receives Tempo Funding | https://ileria.com/news/ileria-oy-receives-tempo-funding/
[LinkedIn, retrieved 2024] Ileria Oy LinkedIn Page | https://www.linkedin.com/company/ileria
[ileria.com, retrieved 2024] Ileria Oy Website | https://ileria.com
[Apple App Store, retrieved 2024] Ileria App Store Listing | https://apps.apple.com/ro/app/ileria/id6758525323
[ileria.com/cpr-feedback-app/, retrieved 2026] CPR Trainer App - Ileria | https://ileria.com/cpr-feedback-app/
[ileria.com/our-story-to-develope-cpr-technology/, retrieved 2026] Our Story to Develop CPR Technology | https://ileria.com/our-story-to-develope-cpr-technology/
[ileria.com, retrieved 2026] Ileria Launches Third Official CPR Training Pilot | https://ileria.com/news/ileria-launches-third-official-cpr-training-pilot/
[Proff.fi, retrieved 2024] Ileria Oy - Y-tunnus 3488145-9 - Tampere | https://www.proff.fi/yrityksen/ileria-oy/tampere/l%C3%A4%C3%A4kint%C3%A4tekniset-laitteet/3488145-9I011I
[businesstampere.com, retrieved 2026] Founders Club Event by Business Tampere | https://businesstampere.com/events/founders-club/
[Grand View Research, 2023] CPR Training Market Size Report | https://www.grandviewresearch.com/industry-analysis/cpr-training-market-report
[Fortune Business Insights, 2024] Automated External Defibrillator (AED) Market Report | https://www.fortunebusinessinsights.com/automated-external-defibrillator-aed-market-101967
[Resuscitation, 2021] Study on CPR Performance Quality | https://www.resuscitationjournal.com/article/S0300-9572(21)00123-4/fulltext
[Laerdal] Laerdal Medical Official Website | https://www.laerdal.com
[Zoll] ZOLL Medical Corporation Official Website | https://www.zoll.com
[CPRight] CPRight Official Website | https://www.cpright.com
[Brayden] Brayden Official Website | https://www.brayden.com
Articles about Ileria Oy
- Ileria's CPR Feedback Device Lands a Finnish Red Cross Pilot — The Tampere-based startup is testing its real-time guidance hardware with first responders, aiming to move from training into emergency use.